Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

35.00
+3.5211.18%
Post-market: 35.110.1100+0.31%19:59 EDT
Volume:4.20M
Turnover:144.36M
Market Cap:6.45B
PE:-29.41
High:35.20
Open:32.32
Low:32.14
Close:31.48
Loading ...

Legend Biotech Reports $369 Million in CARVYKTI® Sales for Q1 2025

TIPRANKS
·
15 Apr

Legend Biotech Corp -Carvykti Generated About $369 Mln in Net Trade Sales During Quarter Ended March 31, 2025

THOMSON REUTERS
·
15 Apr

Johnson & Johnson CEO warns US tariffs may disrupt drug supply

Reuters
·
15 Apr

Pacira (PCRX) Surges 14.7%: Is This an Indication of Further Gains?

Zacks
·
09 Apr

Legend Biotech Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Apr

RBC Capital Keeps Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
05 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Legend Biotech Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
18 Mar

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
17 Mar

Legend Biotech (LEGN) Blockbuster Fuels Expectation-beating Growth

TIPRANKS
·
13 Mar

William Blair Sticks to Their Hold Rating for Legend Biotech (LEGN)

TIPRANKS
·
12 Mar

Legend Biotech Corp (LEGN) Q4 2024 Earnings Call Highlights: Record CARVYKTI Sales and ...

GuruFocus.com
·
12 Mar

Q4 2024 Legend Biotech Corp Earnings Call

Thomson Reuters StreetEvents
·
12 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney

Reuters
·
12 Mar

Genscript Biotech Announces Legend Biotech’s 2024 Financial Results

TIPRANKS
·
11 Mar

BUZZ-Legend Biotech gains on narrower Q4 loss

Reuters
·
11 Mar

Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics

Zacks
·
11 Mar

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT Newswires Live
·
11 Mar

Legend Biotech's Q4 Net Loss Narrows, Revenue Rises

MT Newswires Live
·
11 Mar

Legend Biotech Q4 2024 Adj EPS $(0.16) Beats $(0.33) Estimate, Sales $186.52M Beat $178.93M Estimate

Benzinga
·
11 Mar